Literature DB >> 15372412

Endothelial dysfunction and oxidative stress in chronic renal failure.

Lorenzo Ghiadoni1, Adamasco Cupisti, Yale Huang, Paola Mattei, Heloise Cardinal, Stefania Favilla, Paolo Rindi, Giuliano Barsotti, Stefano Taddei, Antonio Salvetti.   

Abstract

Uremic patients have an increased incidence of cardiovascular disease (CVD), endothelial dysfunction and oxidative stress that can contribute to cardiovascular (CV) events. To assess the relationship between endothelial dysfunction, oxidative stress and renal failure severity, we studied 40 patients (age 57 +/- 7 yrs, 24 males) affected by chronic kidney disease (CKD) K/DOQI stage 3-5 (serum creatinine (Cr) 5.6 +/- 2.2 mg/dL) on conservative treatment, 20 uremic patients (age 57 +/- 12 yrs, 13 males) on hemodialysis (HD) and 30 healthy controls (56 +/- 12 yrs, 20 males). Before and 2 hr after oral vitamin C (2 g) administration, we measured brachial artery endothelium-dependent vasodilation (flow mediated dilation (FMD)) to reactive hyperemia following 5 min of forearm ischemia and the response to sublingual glyceril trinitrate (GTN). Measurements were made by high-resolution ultrasound and computerized analysis. FMD was lower in CKD patients than in controls (5.3 +/- 2.2 vs. 6.9 +/- 2.8%; p<0.01) and was further reduced in HD patients (3.6 +/- 2.7; p<0.01 vs. CKD patients). Response to GTN was similar in all groups. FMD was related to Cr clearance (r=0.42; p<0.01) in CKD patients, while it related inversely to Kt/V(urea) (r=-0.52; p<0.05) in HD patients. After vitamin C administration, FMD was significantly enhanced in HD (4.7 +/- 2.4%; p<0.01 vs. baseline), but not in CKD patients. Response to GTN was unaffected. However, vitamin C load reduced oxidative stress markers, and increased plasma antioxidant capability in both groups. In conclusion, the reduced endothelium-dependent dilation in the brachial artery of CKD patients is related to renal failure severity. HD patients showed a more marked alteration, which seems to be related, at least in part, to increased oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15372412

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  54 in total

1.  Racial differences in the association of pentraxin-3 with kidney dysfunction: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Ruth Dubin; Michael Shlipak; Yongmei Li; Joachim Ix; Ian H de Boer; Nancy Jenny; Carmen A Peralta
Journal:  Nephrol Dial Transplant       Date:  2010-11-15       Impact factor: 5.992

2.  Xanthine oxidase and the beneficial effect of allopurinol on blood pressure and renal function.

Authors:  Xu Duan
Journal:  Int Urol Nephrol       Date:  2008-08-07       Impact factor: 2.370

Review 3.  Nocturnal hemodialysis.

Authors:  Paramjit Kalirao; Joshua M Kaplan
Journal:  Clin Exp Nephrol       Date:  2009-01-20       Impact factor: 2.801

4.  Ascorbic acid or L-arginine improves cutaneous microvascular function in chronic kidney disease.

Authors:  Jennifer J Dupont; William B Farquhar; Raymond R Townsend; David G Edwards
Journal:  J Appl Physiol (1985)       Date:  2011-09-01

5.  NADPH oxidase-derived reactive oxygen species contribute to impaired cutaneous microvascular function in chronic kidney disease.

Authors:  Jennifer J DuPont; Meghan G Ramick; William B Farquhar; Raymond R Townsend; David G Edwards
Journal:  Am J Physiol Renal Physiol       Date:  2014-04-23

Review 6.  Evaluation of endothelial function by flow mediated dilation: methodological issues and clinical importance.

Authors:  Lorenzo Ghiadoni; Massimo Salvetti; Maria Lorenza Muiesan; Stefano Taddei
Journal:  High Blood Press Cardiovasc Prev       Date:  2014-03-12

7.  Vascular Function and Uric Acid-Lowering in Stage 3 CKD.

Authors:  Diana I Jalal; Emily Decker; Loni Perrenoud; Kristen L Nowak; Nina Bispham; Tapan Mehta; Gerard Smits; Zhiying You; Douglas Seals; Michel Chonchol; Richard J Johnson
Journal:  J Am Soc Nephrol       Date:  2016-09-12       Impact factor: 10.121

8.  Role of mitochondria-derived reactive oxygen species in microvascular dysfunction in chronic kidney disease.

Authors:  Danielle L Kirkman; Bryce J Muth; Meghan G Ramick; Raymond R Townsend; David G Edwards
Journal:  Am J Physiol Renal Physiol       Date:  2017-11-08

Review 9.  Endothelial dysfunction as a target for prevention of cardiovascular disease.

Authors:  Daniele Versari; Elena Daghini; Agostino Virdis; Lorenzo Ghiadoni; Stefano Taddei
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

Review 10.  Circulating endothelial progenitor cells: a new approach to anti-aging medicine?

Authors:  Nina A Mikirova; James A Jackson; Ron Hunninghake; Julian Kenyon; Kyle W H Chan; Cathy A Swindlehurst; Boris Minev; Amit N Patel; Michael P Murphy; Leonard Smith; Doru T Alexandrescu; Thomas E Ichim; Neil H Riordan
Journal:  J Transl Med       Date:  2009-12-15       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.